Trial Profile
A Randomized, Placebo-Controlled, Double-Blind, Two-Part, Cross-over Study in Healthy Adult Male Subjects to Compare the Reduction in Pain Intensity After Single-Dose Administration of Intravenous or Oral Acetaminophen and Intravenous Morphine by Using UVB Burn and Intradermal Capsaicin Experimental Pain Models
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Paracetamol (Primary) ; Paracetamol (Primary) ; Morphine
- Indications Pain
- Focus Therapeutic Use
- Sponsors Mallinckrodt Inc.
- 09 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 25 May 2016 Planned End Date changed from 1 Jul 2016 to 1 Aug 2016.
- 01 Mar 2016 Planned number of patients changed from 48 to 62 as reported by ClinicalTrials.gov.